Retraction Note to: Mol Cancer 10, 115 (2011)
https://doi.org/10.1186/1476-4598-10-115
The Editor-in-Chief has retracted this article after an investigation by Harvard Medical School and Beth Israel Deaconess Medical Center and additional analysis by the Office of Research Integrity found:
Reuse and relabelling of the same source bands to falsely represent different experimental results in Figure 3A (first four lanes in the middle row of the left panel representing c-myc expression in nucleus of A375 cell type, and first four lanes in the middle row of the right panel representing c-myc expression in nucleus of SK MEL 5 cell type)
Reuse and relabelling of the same source bands to falsely represent different experimental results in Figure 5 (sixth to eighth lanes of the middle row representing BCL-XL expression in A375-GSK cells with DOX, and last three lanes of the middle row representing BCL-XL expression in SK MEL 5 S9A)
Reuse and relabelling of unrelated source bands falsely represent different experimental results in Figure 5 (thirteenth to fifteenth lanes of the top row representing BCL2 expression in SK MEL 5 S9A, and thirteenth to fifteenth lanes of the bottom row representing VINCULIN expression in SK MEL 5 S9A)
James W Mier agrees with this retraction. David J Panka does not agree with this retraction. The Editor-in-Chief has not been able to find a current email address for Qingjun Liu.